Filing Flows

Filing Flows › Companies › Evolus › Cash flow

Evolus cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$2.3M in Q3 2026 · −$4.9M over twelve months

Operating cash flow−$1.9M
Capital spending−$320K
Free cash flow−$2.3M
Cash conversion cycle61 days

Analysis

In Q3 2026, Evolus generated −$1.9M of operating cash flow and spent $320K on capital projects, leaving free cash flow of −$2.3M. That is $13.4M more than in Q3 2025 (−$15.6M).

Over the twelve months to Sep 30, 2026, operating cash flow was −$2.6M; the largest uses were other investing ($3.9M), operating cash flow ($2.6M), capital spending ($2.3M); besides operations, cash came from other financing ($7.4M); the cash balance fell by $1.8M.

Operating cash flow was −$1.9M against net income of −$12.5M. The largest differences: stock-based pay +$5.6M, depreciation & amortization +$2.4M, prepaid and other assets +$1.8M.

Its cash conversion cycle was 61 days (receivables 72 + inventory 209 − payables 220).

Free cash flow

Evolus: free cash flow by quarterEvolus: free cash flow by quarter$4.4MQ4 2024−$16.0MQ1 2025−$25.5MQ2 2025−$15.6MQ3 2025$11.3MQ4 2025−$10.4MQ1 2026−$3.6MQ2 2026−$2.3MQ3 2026
Operating cash flow less capital spending.
Evolus: operating cash flow against capital spendingEvolus: operating cash flow against capital spendingOperating cash flowCapital spending$4.8M$438KQ4 2024−$15.6M$319KQ1 2025−$24.8M$688KQ2 2025−$14.7M$955KQ3 2025$12.8M$1.5MQ4 2025−$10.0M$415KQ1 2026−$3.6M$50KQ2 2026−$1.9M$320KQ3 2026
Latest (Q3 2026): Operating cash flow −$1.9M, Capital spending $320K.

Capital allocation, year by year

Evolus: where the cash came from (up) and went (down), by fiscal yearEvolus: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY2021: Operating cash flow −$33.4MFY2021: Capital spending −$393KFY2021FY2022: Operating cash flow −$84.9MFY2022: Shares issued $539KFY2022: Capital spending −$1.6M$539KFY2022FY2023: Operating cash flow −$34.0MFY2023: Net borrowing $50.0MFY2023: Shares issued $231KFY2023: Capital spending −$473K$50.2MFY2023FY2024: Operating cash flow −$18.0MFY2024: Shares issued $56.1MFY2024: Capital spending −$1.5M$56.1MFY2024FY2025: Operating cash flow −$42.3MFY2025: Net borrowing −$15KFY2025: Capital spending −$3.4MFY2025
Over these 5 years operating cash flow totalled −$213M; the largest uses were operating cash flow ($213M) and capital spending ($7.4M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$41.7M
Debt$157M
Net debt$115M
Cash runway8.5 years

Evolus is burning cash: its operations consume cash, a free cash flow of −$4.9M a year at the current rate against $41.7M of cash and investments: a runway of about 8.5 years before any new financing.

Where the cash came from and went

Evolus: sources (+) and uses (−) of cash, Q3 2026Evolus: sources (+) and uses (−) of cash, Q3 2026Cash drawn (+) / kept (−)$3.5MOperating cash flow−$1.9MOther investing−$1.5MCapital spending−$320KExchange rates$176KOther financing$106KNet borrowing (+) / repaid (−)−$5K
Evolus: sources (+) and uses (−) of cash, TTM to Q3 2026Evolus: sources (+) and uses (−) of cash, TTM to Q3 2026Other financing$7.4MOther investing−$3.9MOperating cash flow−$2.6MCapital spending−$2.3MCash drawn (+) / kept (−)$1.8MExchange rates−$439KNet borrowing (+) / repaid (−)−$17K

From profit to cash

Evolus: net income to operating cash flow, Q3 2026Evolus: net income to operating cash flow, Q3 2026Net income−$12.5MDepreciation & amortization$2.4MStock-based pay$5.6MDeferred taxes−$326KReceivables$1.3MInventory−$1.3MPayables−$209KAccrued liabilities−$1.2MPrepaid and other assets$1.8MOperating cash flow−$1.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 20267220922061
Q2 20266211110865
Q1 202666968082
Q4 202554896974
Q3 2025651189291
Q2 202562697557
Q1 202562465256
Q4 202454474061

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q3 2026−$1.9M−$320K−$5K$3.5M−$2.3M
Q2 2026−$3.6M−$50K−$4K$4.6M−$3.6M
Q1 2026−$10.0M−$415K$10.0M$4.0M−$10.4M
Q4 2025$12.8M−$1.5M−$4K−$10.3M$11.3M
Q3 2025−$14.7M−$955K−$4K$18.2M−$15.6M
Q2 2025−$24.8M−$688K−$7K$6.2M−$25.5M
Q1 2025−$15.6M−$319K—$19.1M−$16.0M
Q4 2024$4.8M−$438K—−$1.9M$4.4M

Evolus: income statement and cash flow

Evolus, Q3 2026: revenue $78.0M (+13% year over year), operating margin -10.8%. The chart follows the revenue to costs, profit and cash.

Evolus: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.